Arca
Skip to content
Tools
Tools

Dyslipideamia

Drug research and approvals for dyslipideamia: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 0 studies of dyslipideamia are recruiting on ClinicalTrials.gov, and Health Canada has authorized 7 drug trials for it since 2013.

  • Recruiting worldwide: 0
  • Trials authorized in Canada: 7
  • FDA orphan approvals: 0
  • EU medicines: 0

Trials authorized in Canada

Newest first; search them all in Canada trials
Aug 12, 2022A phase 2 open-label extension study to evaluate the long-term safety and efficacy of aro-APOC3 in adults with dyslipidemiaPlozasiran (ARO-APOC3)Arrowhead Pharmaceuticals, Inc.Closed
May 4, 2021A double-blind, placebo-controlled phase 2b study to evaluate the efficacy and safety of ARO-ANG3 in adults with mixed dyslipidemiaZodasiran (ARO-ANG3, ADS-004)Arrowhead Pharmaceuticals, Inc.Closed
Aug 20, 2020A phase 2b randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to assess the efficacy, safety, and tolerability of vupanorsen…Vupanorsen (PF-07285557, isis 703802)PfizerClosed
Oct 8, 2014A phase-3, double-blind, double-dummy, randomized, placebo and active controlled, parallel-group study to assess the efficacy, safety, and tolerability of…RN316 (PF-04950615)PfizerOngoing
May 16, 2014A phase 3 double-blind, randomized, placebo-controlled, parallel-group study to assess the efficacy, safety and tolerability of PF-04950615 in subjects with…RN316 (PF-04950615)PfizerOngoing
Mar 28, 2014A double-blind, randomized, placebo-controlled, multicenter study to evaluate safety and efficacy of evolocumab (amg 145) in combination with statin therapy in…Evolocumab (amg 145)AmgenOngoing
Oct 2, 2013Effects of selective inhibition of cholesterol absorption with ezetimibe on intestinal cholesterol homeostasis in dyslipidemic men with insulin-resistance - a…EzetimibeDr. Patrick CouturePending

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.